Ethicann Pharmaceuticals uses pharmaceutical grade botanically sourced cannabinoid oils to formulate ethical drugs.The company was formed in 2018 as a global pharma enterprise, by founders with extensive experience in the Canadian and US Pharma and Cannabis industries. Over the last 10 months, the company has achieved a number of importantmilestones to further its business plan. For example, Ethicann's US subsidiary recently held a successful Pre-IND meeting with the US Food and Drug Administration ("FDA") to discuss the 505(b)(2) requirements for a marketing approval for its first product (CAN-001) to treat chemotherapy-induced nausea and vomiting. Ethicann is now finalizing its development and manufacturing agreements with a licensed cannabis producer/extractor to provide investigational pharmaceutical drugs.

Ethicann Pharmaceuticals

Similar companies